During the past decade, Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Kowa Research Institute, Inc." with 2 trials sponsored, "4Living Biotech" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Incyte Corporation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD" are "Severe Hypertriglyceridemia" (2 trials), "Asthma" (1 trials), "Breast Cancer" (1 trials), "COVID-19" (1 trials) and "COVID-19 Acute Respiratory Distress Syndrome" (1 trials). Many other conditions were trialed in "Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD" in a lesser frequency.

Most popular intervention types in "Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD" are "Drug" (11 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials) and "Apabetalone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD" are 9 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".